Results 21 to 30 of about 1,122,733 (261)

Humoral response to viral vector COVID-19 vaccine in hemodialysis patients [PDF]

Kidney Research and Clinical Practice, 2022
Background The coronavirus disease 2019 (COVID-19) vaccine is not readily available in many countries where dosing interval is spaced more than ideal. Patients with chronic kidney disease, especially those on maintenance hemodialysis, have a tendency for
Niranjan Raja, Arul Rajagopalan, Jegan Arunachalam, Arun Prasath, Rakesh Durai, Manorajan Rajendran   +5 more
doaj   +1 more source

Therapies for Chronic Allograft Rejection

Frontiers in Pharmacology, 2021
Remarkable advances have been made in the pathophysiology, diagnosis, and treatment of antibody-mediated rejection (ABMR) over the past decades, leading to improved graft outcomes.
Min Young Kim, Daniel C. Brennan
doaj   +1 more source

Peptides Derived From Mismatched Paternal Human Leukocyte Antigen Predicted to Be Presented by HLA-DRB1, -DRB3/4/5, -DQ, and -DP Induce Child-Specific Antibodies in Pregnant Women

Frontiers in Immunology, 2021
Predicted Indirectly ReCognizable Human Leukocyte Antigen (HLA) Epitopes (PIRCHE) are known to be a significant risk factor for the development of donor HLA-specific antibodies after organ transplantation.
Matthias Niemann, Benedict M. Matern, Eric Spierings, Stefan Schaub, Stefan Schaub, Stefan Schaub, Gideon Hönger, Gideon Hönger, Gideon Hönger   +8 more
doaj   +1 more source

ANTIBODY FORMATION [PDF]

The Journal of Experimental Medicine, 1963
Injection of a sufficient dose of bacteriophage ϕX 174 into guinea pigs results in the formation of rapidly sedimenting antibody molecules (19S), and later, slowly sedimenting molecules (7S). Above a threshold dose of antigen, the relative rate of 19S formation is maximal and dose-independent; below this dose, slower relative rates are obtained.
Martin S Finkelstein, Jonathan W Uhr
openaire   +1 more source

Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients

Vaccines, 2022
The COVID-19 pandemic continues to be a worldwide health issue. Among hemodialysis (HD) patients, two-dose immunization schemes with mRNA vaccines have contributed to preventing severe COVID-19 cases; however, some have not produced a sufficient humoral ...
José Jesús Broseta, Diana Rodríguez-Espinosa, Elena Cuadrado, Néstor Rodríguez, José Luis Bedini, Francisco Maduell   +5 more
doaj   +1 more source

Measles vaccination in children with neurological disorders

Журнал инфектологии, 2014
The data on the current vaccination process and specific antibody in 212 children with pathology of nervous systems in age from 1 year to 6 years old, vaccinated against measles. The comparison group consisted of 36 children without neurological disease.
S. P. Kaplina, S. M. Kharit, O. V. Goleva, E. I. Aleksandrova   +3 more
doaj   +1 more source

A Role for the Transcription Factor Arid3a in Mouse B2 Lymphocyte Expansion and Peritoneal B1a Generation

Frontiers in Immunology, 2017
The initiation, commitment, and terminal differentiation of the B cell lineage is stringently controlled by the coordinated action of various transcription factors.
Katrin Habir, Shahin Aeinehband, Fredrik Wermeling, Stephen Malin   +3 more
doaj   +1 more source

THE ANTIBODY-FORMATION BY POLYSACCHARIDS [PDF]

Journal of Experimental Medicine, 1929
1. By complement fixation tests, it has been clearly demonstrated that the sera of rabbits immunized with inulin, soluble starch and dextrine contain specific antibodies. 2. All these immune sera gave a negative precipitation reaction. 3.
openaire   +2 more sources

Prevalência de aloimunização eritrocitária em pacientes portadores de anemia falciforme

ABCS Health Sciences, 2017
Embora as transfusões de concentrado de hemácias sejam importantes para o tratamento de pacientes com anemia falciforme, elas acarretam riscos imunológicos tais como a aloimunização a antígenos eritrocitários.
Alexandre Gomes Vizzoni, Heladya Maria Matos Moreira   +1 more
doaj   +1 more source

Low disease activity of microscopic polyangiitis in patients with anti-myosin light chain 6 antibody that disrupts actin rearrangement necessary for neutrophil extracellular trap formation

Arthritis Research & Therapy, 2022
Background Neutrophil extracellular traps (NETs) are critically involved in microscopic polyangiitis (MPA) pathogenesis, and some patients with MPA possess anti-NET antibody (ANETA). Anti-myosin light chain 6 (MYL6) antibody is an ANETA that affects NETs.
Miku Yoshinari, Yuka Nishibata, Sakiko Masuda, Daigo Nakazawa, Utano Tomaru, Yoshihiro Arimura, Koichi Amano, Yukio Yuzawa, Ken-Ei Sada, Tatsuya Atsumi, Hiroaki Dobashi, Hitoshi Hasegawa, Masayoshi Harigai, Seiichi Matsuo, Hirofumi Makino, Akihiro Ishizu   +15 more
doaj   +1 more source